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Background: Over one million people in Uganda are estimated to be infected with HIV and about 20% of these
were already accessing antiretroviral therapy (ART), by 2010. There is a dearth of data on adherence to antiretroviral
therapy and yet high client load on a weak and resource constrained health system impacts on provision of quality
HIV/AIDS care. We assessed adherence to standards of HIV care among health workers in the West Nile Region of
Uganda.
Methods: We conducted a cross sectional study in nine health facilities. Records of a cohort of 270 HIV clients that
enrolled on ART 12 months prior were assessed. The performance of each health facility on the different indicators
of standards of HIV/AIDS care was determined and compared with the recommended national guidelines.
Results: We found that 94% of HIV clients at all the facilities were assessed for ART eligibility using WHO clinical
staging while only two thirds (64.8%) were assessed using CD4. Only 42% and 37% of HIV clients at district hospitals
and health centers respectively, received basic laboratory work up prior to ART initiation and about a half (46.7%) of
HIV clients at these facilities received the alternative standard 1st line antiretroviral (ARV) regimen. Standards of ART
adherence and tuberculosis assessment declined from over 70% to less than 50% and from over 90% to less than
70% respectively, during follow up visits with performance being poorer at the higher level regional referral facility
compared to the lower level facilities.
Conclusions: Adherence to standards of HIV/AIDS care at facilities was inadequate. Performance was better at the
start of ART but declined during the follow up period. Higher level facilities were more likely to adhere to standards
like CD4 monitoring and maintaining HIV clients on standard ARV regimen. Efforts geared towards strengthening
the health system, including support supervision and provision of care guidelines and job aides are needed,
especially for lower level facilities.Background
Over 34 million people worldwide, are estimated to be liv-
ing with the HIV infection and 2.7 million new HIV infec-
tions as well as 1.8 million AIDS deaths occurred by the
end of 2010 [1]. The devastating nature of the epidemic is
likely to over burden the health systems in many develop-
ing countries, especially those in Sub-Saharan Africa
which accounts for 67% of all people living with HIV and
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unless otherwise stated.remains a serious public health challenge in Uganda, con-
tributing to a disproportionately high burden of morbidity
and mortality. The Uganda Ministry of Health (MOH) es-
timated 110,000 new HIV infections to have occurred in
2008 and that the disease has killed approximately one
million people, substantially lowering the life expectancy
and resulting in over a million orphaned children [2].
Availability of antiretroviral drugs has contributed to
global reductions in AIDS-related deaths in recent years.
It is estimated that access to antiretroviral therapy
(ART) in low and middle income countries increased to
6.65 million in 2010, representing 47% coverage of
people eligible for treatment [1]. The provision of quality
HIV/AIDS care and antiretroviral therapy is importanttd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
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ease. However, to be effective, provision of ART must be
of the highest quality. Quality HIV/AIDS care is defined
as performance according to recommended standards of
care and involves interventions that are known to be
safe, affordable and have ability to mitigate morbidity
and mortality among HIV infected clients [3]. Standards
of quality HIV/AIDS care are expectations of performance
and represent a generic statement of what is expected of
the HIV therapy service site. They help improve the qual-
ity of care offered, shape positive service provision behav-
ior, remove unwanted variation in care processes and
provide a frame-work for measuring results [3].
In Uganda, the AIDS Control Program (ACP) adapted
the World Health Organization (WHO) standards of
quality HIV/AIDS care, based on the national norms
and needs of the country [2]. Some of the WHO stan-
dards adapted to the Ugandan context include: i) Provision
of cotrimoxazole prophylactic therapy for all people living
with HIV; ii) Routine screening of active tuberculosis (TB)
among people living with HIV; iii) Assessment of ART eli-
gibility using WHO clinical eligibility criteria or CD4 cell
count; iv) Provision of standard ART regimen for eligible
HIV clients and v) ART adherence monitoring.
WHO recommends the use of Cotrimoxazole Prophy-
lactic Therapy (CPT) for patients with symptomatic HIV
infection [4]. A number of studies have also shown that
Cotrimoxazole prophylactic therapy prevents the occur-
rence of fatal opportunistic infections among patients
with HIV [5,6]. The Uganda national ART guidelines rec-
ommend CPT for all HIV infected adults and children
regardless of whether they are on antiretroviral therapy
or not [7].
The World Health Organization estimates that about
5-15% of people living with HIV (PLHIV) have active tu-
berculosis (TB) based on symptom screening. Hence
WHO recommends that all PLHIV need to be evaluated
for active TB disease through intensified case-finding at
the time of initial HIV diagnosis and during follow-up
[4]. Evidence has also shown that intensified case-finding
and treatment of TB among HIV infected persons inter-
rupts disease transmission [8-10]. In light of this, the
Ugandan Ministry of Health introduced intensified TB
case finding tools at all care entry points, including the
HIV/ART clinic to screen for active TB among HIV clients
receiving care and there is provision to monitor the TB
status of all HIV clients in the patient records. However,
uptake of intensified case finding of TB is hampered by
poor staff attitude towards the added documentation and
ensuring that all the presumed TB cases receive appropri-
ate laboratory tests.
Another key standard for ART in Uganda is assess-
ment of ART eligibility using WHO clinical eligibility
criteria or CD4 cell count. According to the UgandanART guidelines, the decision to initiate ART is based on
the WHO clinical staging and CD4. WHO clinical sta-
ging criteria are a set of signs and symptoms of opportun-
istic infections or disease that affect people living with
HIV. They manifest and are graded in severity from stage
I - IV with declining immune status of the patient. How-
ever, in ideal situations, a CD4 count is essential for ART
initiation and subsequent monitoring of the patients [2].
In Uganda, despite rigorous criteria for determining
HIV clients eligible for ART, not all HIV clients in need
of ART have access to treatment. It was for instance es-
timated that, 230,000 (42%) out of the 550,000 patients
in need of ART accessed the services by end of 2010
[11]. The low uptake of ART is attributed to various
challenges including inadequate skilled staff, high work-
load and lack of motivation among providers, lack of
equipment/supplies, drug stock outs and inadequate sys-
tems to ensure that eligible patients are initiated and
retained on ART [11]. Less than half (49%) of recom-
mended medical staffing positions at hospital level in
Uganda are filled [12]. There is also limited capacity at
the regional and district level to conduct adequate sup-
port supervision and ensure providers adhere to recom-
mended standards of quality HIV/AIDS care.
A possible consequence of rapid ART scale up in a weak
health system is failure to adhere to standards of HIV/
AIDS care leading to poor quality services. However, there
is a dearth of data on how well clinicians in Uganda adhere
to HIV/AIDS treatment guidelines. Hence the purpose of
the study was to assess adherence of health facilities to
standards of quality HIV/AIDS care in the country.
Methods
Study setting
The study was conducted in the West Nile region,
located in the north western part of Uganda. It comprises
8 districts and has a total population of about 1,800,000
people who are predominantly subsistence farmers. The
region has a total fertility rate of 7.2 per woman, which is
slightly higher than the national average of 6.9 [13].
There are a total of 199 health facilities including a
Regional referral hospital; General hospitals (9); Health
Center IV’s (7); Health Center III’s (80); and Health
Center II’s (92). A total of 20 health facilities were accre-
dited by the MOH to provide ART in West Nile in 2008
[14]. These included one regional referral hospital, 8
general level hospitals, 8 health centre IV’s and 3 health
centre III’s. The Uganda MOH maintains an accredit-
ation system for facilities providing ART so as to ensure
adherence to performance standards and to improve the
quality of services provided. Facilities are authorized to
provide ART if they meet set guidelines/standards which
include availability of trained staff; accessible HIV coun-
seling and testing; functioning laboratory services; a
Table 1 Distribution of the facilities according to various
characteristics (N = 9)
Characteristic Frequency (n) Percentage (%)
Ownership
Public 6 66.7
Faith Based/PNFP 3 33.3
Level
Regional referral hospital 1 11.1
General hospital 6 66.7




ART Client load as at June 2010
1000 - 6000 clients 2 22.2
301 - 999 clients 3 33.3
100 - 300 clients 4 44.5
ART: Anti Retroviral Therapy.
PNFP: Private Not For profit.
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ing follow up and referral system [14]. The MOH en-
sures that the standards are observed and monitored
through trainings, provision of management protocols
and support supervision.
Study design, sampling and data collection
This was a cross sectional study conducted in 9 health
facilities that met the selection criteria: Active health fa-
cilities in West Nile region that are accredited by the
MOH to provide ART and records of HIV clients who
were started on ART at least 12 months prior to the
study. Accredited health facilities that were not active at
the time of the assessment or had provided ART for less
than one year and records of HIV clients who trans-
ferred in to the facility less than 12 months before data
collection were excluded.
Records of 270 clients from the 9 health facilities that
met the selection criteria were examined. Each health fa-
cility contributed a minimum sample of 30 client records
(30 × 9 health facilities) to make up the total sample size.
All the nine health facilities that met the selection cri-
teria were purposively included in the sample. Records
of the eligible HIV clients that met the selection criteria
were obtained through systematic sampling. The sam-
pling population (N) for each facility (cohort of HIV cli-
ents that started ART at least 12 months prior to the
study i.e. in the months of April - June 2009 was deter-
mined). The sampling population was then divided by
30 (the required sample size for each health facility) to
get the sampling interval. The first file to be reviewed
was randomly selected by flipping through the row of
files while the subsequent files were identified by skip-
ping and picking the file after every sampling interval for
that facility, until when the last file was reached. This
made up for the required sample size of 30 per facility
and 270 for all the 9 facilities surveyed. In facilities
where less than 30 patients enrolled on ART in that quar-
ter, records of HIV/AIDS clients who enrolled in the pre-
ceding quarter of (Jan-Mar 2009) were considered.
Standards of quality HIV/AIDS care and ART were
measured using indicators that represent the rate of ac-
complishment of the standard or the expected threshold.
These included:
1) Proportion of HIV positive clients on ART who
were prescribed daily cotrimoxazole
2) Proportion of HIV positive clients on ART who
were assessed for active TB during each clinical
follow up visit
3) Proportion of HIV positive clients on ART who
were assessed for ART eligibility (using WHO
clinical stage or CD4 count), prior to ART
initiation)4) Proportion of HIV positive clients on ART who
were prescribed a standard ART regimen at the start
of treatment
5) Proportion of HIV positive clients on ART who
were assessed for adherence to antiretroviral (ARV)
medicines on every clinic visit
6) Availability of basic laboratory tests for monitoring
toxicity and response to ART.
7) Availability of ARV drugs, TB drugs and other
medicines for treating opportunistic infections (O.I)
Quantitative data on adherence to clinical standards of
HIV/AIDS was collected using an HIV/ART care cohort
review form , a tool adapted from WHO and validated
for use by the MOH/ACP for conducting cohort analysis
of HIV clients enrolled on ART after every 6 months on
treatment. Data on availability of drugs and supplies as
well as laboratory functionality was collected using a fa-
cility observation check list adapted from the MOH
health unit bi-monthly medicines availability and order
checklist developed by the national Medical Stores.
Data analysis
Data collected was cross checked for completeness and
accuracy before being entered into Epi info version 3.5.1
and exported to Microsoft Access for further re-coding.
Analysis was carried out in SPSS version 16 for windows
and involved the estimation of proportions. Basic infor-
mation about health facilities was analyzed according to
the name, district, ownership, level and location.
Indicators to measure the standards of quality HIV
care were analyzed as proportions with the number of










WHO stage 16 (53.3%) 178 (98.9%) 60 (100.0%) 254 (94.1%) 100.59 <0.001
CD4 count 29 (96.7%) 114 (63.3%) 32 (53.3%) 175 (64.8%) 17.0 < 0.001
Basic lab tests 23 (76.7%) 76 (42.2%) 22 (36.7%) 121 (44.8%) 14.4 0.001
Prescribed preferred 1st line ARV regimen
(AZT/3TC/NVP or EFV)
28 (93.3%) 126 (70.0%) 32 (53.3%) 186 (68.9%) 15.24 <0.001
*degrees of freedom; AZT - Zidovudine; 3TC - Lamivudine; NVP - Nevirapine; EFV - Effervirenz.
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merator and the total number of clinical sessions or op-
portunities for complying the standard in the denominator.
The performance of each health facility on the different in-
dicators of standards of care was determined and com-
pared to the national benchmarks.
Permission to conduct the study was obtained from
the Uganda National Council for Science and Technology
after the Makerere University Higher Degrees Research
and Ethics Committee granted ethical approval. Permis-
sion was also obtained from the District Health Office
supervising the respective health facilities. Unique codes
were used to identify individual patient records in order to
ensure confidentiality.
Results
Two thirds of the facilities were public institutions and
at the level of a general hospital while over half
(55.6%) of the facilities were located in rural settings
(Table 1). Prior to ART initiation, 254 (94.1%) of the





% of HIV clients in care who are prescribed daily
cotrimoxazole
100.0 99.3
% of HIV clients in care who are assessed for active
TB on every visit
3.4 86.3
% of HIV clients done WHO clinical stage at baseline 53.3 100.0
% of HIV clients done CD4 at baseline 96.7 83.3
% of HIV clients starting ART prescribed an
appropriate ARV regimen
100.0 100.0
% of HIV clients on ART provided ART adherence
counseling on every clinic visit
25.0 50.0
% of HIV clients eligible for ART who get laboratory
work up before initiating ART
76.7 66.7
% of clients on ART who get at least one CD4 test
result over a year
36.7 10.0
RRH: Regional Referral Hospital.
TB: Tuberculosis.
WHO: World Health Organization.
CD4: Cluster of Differentiation for T-Lymphocyte.
ART: Anti Retroviral Therapy.ART eligibility using WHO clinical staging and the dif-
ference by level of facility was statistically significant
(χ2 = 100.59, P = <0.001) (Table 2).
On average about two thirds (64.8%) of the HIV clients
obtained a baseline CD4 test. However, almost all
(96.7%) of HIV clients enrolled in care at the regional re-
ferral hospital obtained a baseline CD4 test compared to
only 53.3% of clients in the health centers and 63.6% of
those in general level hospitals. Similarly, about three
quarters (76.7%) of HIV clients in the regional referral
hospital obtained basic laboratory work-up prior to initi-
ating ART. There was a statistically significant difference
in the proportion of HIV clients that obtained basic la-
boratory work-up prior to initiating ART by level of fa-
cility (χ2 = 14.4, P = 0.001). Ninety three percent of HIV
clients at the regional referral hospital and only half
(53.3%) of HIV clients at the health centers were pre-
scribed the preferred 1st line ARV combination recom-
mended by the MOH (Table 2). The general hospitals
and the health centers still had a notable proportion















98.5 98.5 99.7 93.8 94.4 97.2 97.1
76.5 98.7 88.3 68.0 94.3 100.0 78.1
30.0 100.0 96.7 100.0 96.7 100.0 100.0
7.0 90.0 76.7 66.7 97.7 3.3 46.7
100.0 100.0 100.0 100.0 100.0 100.0 100.0
56.0 88.0 99.0 59.0 80.0 72.0 49.0
6.7 76.7 10.0 56.7 76.7 13.3 20.0
3.3 6.7 16.7 10.0 16.7 0.0 3.3
Figure 1 Proportion of HIV clients on antiretroviral therapy
assessed for adherence to treatment. Hosp: Hospital.
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longer being promoted at facilities, except in special cir-
cumstances such as for children under 5 years and when
the preferred ART regimen is not available.
Only 25% and on average 50% and 75% of the HIV cli-
ents on ART at the regional referral hospital, health cen-
ters and the district hospitals respectively, were assessed
for adherence to ART during the follow up visits (Table 3).
There was a general reduction in the proportion of HIV
clients on ART that were assessed for adherence to treat-
ment during follow up , from over 60% during initial visits
at both general hospitals and health centers to about 50%
over the 12 months while in care. The regional referral
hospital improved over time up to tenth visit but still de-
clined towards the last visits (Figure 1).
Only 3.4% of the HIV clients at the regional referral
hospital had their TB status checked during each clinic
visit. By contrast, an average of 88% of clients in both
general hospitals and health centers had their TB status
checked during each clinic visit (Table 3). The trends in
performance at the facilities showed a general decline in
observing the standard during the subsequent clinic
visits, particularly at the general hospitals and the health
centers, from over 90% during the initial 1–3 visits to
about 75% in the subsequent visits (Figure 2).Figure 2 Proporation of HIV clients on antiretroviral therapy assessedDiscussion
We found that adherence to HIV/AIDS diagnostic and
treatment guidelines were generally poor across all the
health facilities assessed in Uganda’s West Nile region.
Apart from the regional referral hospital which assessed
clients for CD4 count, most health facilities still relied
on the WHO clinical staging criteria to determine eli-
gibility for starting ART. This practice is contrary to
Uganda’s ART guidelines which clearly specify that the
decision to initiate ART should be based on both the clin-
ical staging and CD4 count. A CD4 count is essential for
ART initiation and subsequent monitoring of the patients
hence, anyone who is put on ART must have blood
drawn for a baseline CD4 cell count within 3 months of
initiation [14].
We also found that most of the facilities did not offer
basic laboratory work up prior to ART initiation con-
trary to the national ART guidelines which recommend
basic laboratory monitoring of HIV clients on ART for
toxicity and treatment response of ART. Shortage of
manpower and laboratory supplies was the major bar-
riers to attaining the required standards of care. Failure
to provide adequate laboratory monitoring to HIV cli-
ents initiating ART exposes patients to the risk of ser-
ious adverse ARV drugs reactions. It may also lead to
delays in changing treatment regimen as treatment fail-
ure may not be detected early. Our findings are similar
to those of an earlier study in Tanzania that found inad-
equate trained personnel and laboratory equipment as
one of the reasons for poor quality ART services [15].
A combination of Zidovudine (AZT), Lamivudine
(3TC) and Nevirapine (NVP) or Effervirenz (EFV) is the
preferred first line Antiretroviral (ARV) regimen for
Uganda. However, we found that a substantial propor-
tion of the lower level facilities (health centers) were not
initiating patients on the preferred first line ARV regi-
men. Stavudine (D4T) based ARV regimen was still be-
ing provided despite the fact that the MOH no longer
recommends it because of the high risk of adverse effectsfor active TB. TB: Tuberculosis. Hosp: Hospital.
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ciated with long term use. Our findings are consistent
with those of an earlier study in Uganda which found that
more than 25% of ART facilities in the country were not
observing the recommended standard for initiating HIV
clients on ART [16]. The findings highlight the gap be-
tween policy and program implementation in the country.
We also found that basic standard of ART adherence
monitoring and screening for active TB during each fol-
low up visit was inadequate particularly at the regional
referral hospital. In addition, the performance of the
other facilities also declined with the subsequent follow
up visits. Our findings mirror earlier studies in Cote d
‘Ivoire and Uganda which found that most facilities
maintained good adherence to standards of quality HIV
care only in the first visit with performance declining
over time [17,18]. The low performance of facilities over
time could be due to heavy patient load and provider
complacence. A study in Uganda by Obua et al. also
noted poor performance in ART adherence monitoring
at facilities particularly with dual organizational pro-
grams i.e. Governmental/Non-Governmental Organization
(NGO) [19]. It is imperative that these gaps be addressed as
long term success of HIV/AIDS care and antiretroviral
therapy requires observation of the required standards.
Failure to do so may result in increased patient morbi-
dity and mortality, and increased risk of developing
antiretroviral drug resistance.
A limitation of our study is that we relied on records
review to determine provider adherence to standards.
Client clinical records may quite often be incomplete or
have inaccurate information such that our findings paint
a different picture of the actual situation. However, we
believe that our findings reflect the Uganda HIV/AIDS
ART treatment program especially in areas that are pre-
dominantly served by public health facilities given that,
our findings are consistent with those of earlier studies
in the country and elsewhere.
Conclusion
We found that adherence to standards of HIV/AIDS
care at facilities in the west Nile region was inadequate.
Performance was better at the start of ART but declined
during follow up visits. Higher level facilities were more
likely to adhere to standards than lower health units,
probably because they are well-equipped and adequately
staffed. The findings have important implications for the
HIV/AIDS management and control strategy in Uganda.
As HIV/AIDS care is scaled up, program managers should
ensure that accredited treatment centers are strongly sup-
ported to adhere to standards. There is a particular need
to ensure that lower level facilities are also well equipped
and adequately staffed in order to improve adherence to
standards of care at these facilities.Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
AB conceived the research idea, carried out data collection, analysis,
interpretation and drafting of the manuscript. FN and PW guided the design
of the study, analysis and interpretation of the data and also reviewed it for
intellectual content. PW supported the entire process by reviewing and
guiding each step in the conduct of the study and development of this
manuscript. All authors’ read and approved the final manuscript.
Acknowledgements
This work was in partial fulfillment for the award of a Masters Degree in
Public Health of Makerere University and did not receive any funding. The
authors thank Susan Kiwanuka, Sebastian Baine and Joseph Kabanda who
provided useful comments to earlier drafts of this manuscript, Edmund
Pacutho for assistance with the study design and analysis of the data. We
also thank all the staff of Makerere University School of Public Health who
made the Masters of Public Health program possible.
The views expressed in this article are those of the authors’ and do not
necessarily reflect the position or policy of Makerere University.
Author details
1Makerere University School of Public Health, College of Health Sciences,
Kampala, Uganda. 2Division of Global Health, Karolinska Institutet, Solnavägen
1, 171 77 Solna, Sweden. 3Management Sciences for Health, Kampala,
Uganda.
Received: 15 June 2013 Accepted: 13 October 2014
References
1. United Nations AIDS (UNAIDS): Global HIV/AIDS Response-Epidemic Update
and Health Sector Progress Towards Universal Access-Progress Report. Geneva:
United Nations AIDS (UNAIDS); WHO; 2011.
2. Ministry of Health STD/AIDS Control Program 2009: Status of the HIV/AIDS
Epidemic in Uganda. In The HIV/AIDS Epidemiological Surveillance Report
2005–7 June. Kampala, Uganda: MOH; 2009.
3. World Health Organization: Standards for Quality HIV Care: A Tool for Quality
Assessment, Improvement and Accreditation. Geneva: WHO; 2004.
4. World Health Organization: Antiretroviral Therapy for HIV Infection in Adults
and Adolescents Recommendations for a Public Health Approach. Geneva:
WHO; 2010.
5. McNaghten AD, Hanson DL, Jones JL: Effects of antiretroviral therapy and
opportunistic illness primary chemoprophylaxis on survival after AIDS
diagnosis Adult/Adolescent Spectrum of Disease Group. AIDS 1999,
13:1687–1695.
6. Grimwade K, Sturm AW, Nunn AJ: Effectiveness of cotrimoxazole
prophylaxis on mortality in adults with tuberculosis in rural South Africa.
AIDS 2005, 19:163–168.
7. Ministry of Health: National Policy Guidelines for Cotrimoxazole Prophylaxis for
People With HIV/AIDS. Kampala, Uganda: MOH; 2006.
8. Harries AD, Maher D, Nunn P: Practical and affordable measures for
protection of health care workers from tuberculosis in low-income
countries. Bull World Health Organ 1997, 75:477–489.
9. DeCock K, Chalsson R: Will DOTS do it? A reappraisal of tuberculosis
control in countries with high rates of HIV infection. Int J Tuberc Lung
Dis 1999, 3:457–467.
10. Nachega J, Coetzee J, Adendorff T: Tuberculosis active case finding in a
mother-to-child HIV transmission prevention program in Soweto, South
Africa. AIDS 2003, 17:1398–1400.
11. Ministry of Health STD/AIDS Control Program: The Integrated National
Guidelines on Antiretroviral Therapy, Prevention of Mother to Child
Transmission of HIV and Infant & Young Child Feeding. 1st edition. Kampala,
Uganda: MOH; 2011.
12. Ministry of Health: Health Facility Level Indicators for Monitoring the National
HIV/AIDS Antiretroviral Therapy Program in Uganda. Kampala, Uganda: MOH;
2007.
13. Uganda Bureau of Statistics (UBOS) and Macro International Inc: Uganda
Demographic and Health Survey. Calverton, Maryland, USA: UBOS and Macro
International Inc; 2006.
Burua et al. BMC Health Services Research 2014, 14:521 Page 7 of 7
http://www.biomedcentral.com/1472-6963/14/52114. Ministry of Health: National Antiretroviral Treatment Guidelines for Adults,
Adolescents and Children. 3rd edition. Kampala, Uganda: MOH; 2009.
15. Mapunjo S, Urassa DP: Quality standards in provision of facility based HIV
care and treatment. A case study from Dar Es Salaam region, Tanzania.
East Afr J Public Health 2007, 4(1):12–18.
16. AIDS Control Program, Ministry of Health: Tracking HIV Drug Resistance in
Facilities Providing Antiretroviral Therapy in Uganda Report of Assessment of
Early Warning Indicators for Antiretroviral Drug Resistance. Kampala, Uganda:
MOH; 2008.
17. Lin YS, Livesley N, Nicholas D, Nguessan J: Assessment of HIV Quality of
Care in Cote d’Ivoire. In Technical report. Published by the USAID Health Care
Improvement Project. Bethesda, MD: University Research Co., LLC; 2009.
18. Kyayise AM, Kyeyagalire R, Livesley N, Kirunda I, Tumwesigye B, Kinoti S,
Katungu D: Private-for-Profit HIV /AIDS Care in Uganda: An Assessment.
In Technical Report Published by the USAID Health Care Improvement Project.
Bethesda, MD: University Research Co., LLC; 2008.
19. Obua C, Gusdal A, Waako P, Chalker JC, Goran T, Wahlström R, The INRUD-IAA
Team: Multiple ART programs creat a dilemma for providers to monitor
ARV adherence in Uganda. Open AIDS J 2011, 5:17–24.
doi:10.1186/s12913-014-0521-5
Cite this article as: Burua et al.: Adherence to standards of quality HIV/
AIDS care and antiretroviral therapy in the West Nile Region of Uganda.
BMC Health Services Research 2014 14:521.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
